Infections and Cystic Fibrosis Unit,
Division of Immunology,
Transplantation and Infectious Diseases,
Infections and Cystic Fibrosis Unit, Division of Immunology, Transplantation and Infectious Diseases
Alessandra Bragonzi has not added Biography.
If you are Alessandra Bragonzi and would like to personalize this page please email our Author Liaison for assistance.
Airway epithelial cell-pathogen interactions.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society Aug, 2004 | Pubmed ID: 15463958
Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes.
Molecular therapy : the journal of the American Society of Gene Therapy Sep, 2005 | Pubmed ID: 15963763
Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model.
The Journal of infectious diseases Aug, 2005 | Pubmed ID: 15995954
Sequence diversity of the mucABD locus in Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
Microbiology (Reading, England) Nov, 2006 | Pubmed ID: 17074897
Biological cost of hypermutation in Pseudomonas aeruginosa strains from patients with cystic fibrosis.
Microbiology (Reading, England) May, 2007 | Pubmed ID: 17464058
Virulence of Burkholderia cepacia complex strains in gp91phox-/- mice.
Cellular microbiology Dec, 2007 | Pubmed ID: 17627623
Pseudomonas aeruginosa infection destroys the barrier function of lung epithelium and enhances polyplex-mediated transfection.
Human gene therapy Jul, 2007 | Pubmed ID: 17638571
The staphylococcal respiratory response regulator SrrAB induces ica gene transcription and polysaccharide intercellular adhesin expression, protecting Staphylococcus aureus from neutrophil killing under anaerobic growth conditions.
Molecular microbiology Sep, 2007 | Pubmed ID: 17697253
In vivo growth of Pseudomonas aeruginosa strains PAO1 and PA14 and the hypervirulent strain LESB58 in a rat model of chronic lung infection.
Journal of bacteriology Apr, 2008 | Pubmed ID: 18083816
Role of biophysical parameters on ex vivo and in vivo gene transfer to the airway epithelium by polyethylenimine/albumin complexes.
Biomacromolecules Mar, 2008 | Pubmed ID: 18275149
Burkholderia cenocepacia strains isolated from cystic fibrosis patients are apparently more invasive and more virulent than rhizosphere strains.
Environmental microbiology Oct, 2008 | Pubmed ID: 18643926
Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence.
American journal of respiratory and critical care medicine Jul, 2009 | Pubmed ID: 19423715
Impact of chronic pulmonary infection with Pseudomonas aeruginosa on transfection mediated by viral and nonviral vectors.
Human gene therapy Mar, 2010 | Pubmed ID: 19788388
Pseudomonas aeruginosa exploits lipid A and muropeptides modification as a strategy to lower innate immunity during cystic fibrosis lung infection.
PloS one , 2009 | Pubmed ID: 20037649
Fighting back: peptidomimetics as a new weapon in the battle against antibiotic resistance.
Science translational medicine Mar, 2010 | Pubmed ID: 20374995
Murine models of acute and chronic lung infection with cystic fibrosis pathogens.
International journal of medical microbiology : IJMM Dec, 2010 | Pubmed ID: 20951086
Positive signature-tagged mutagenesis in Pseudomonas aeruginosa: tracking patho-adaptive mutations promoting airways chronic infection.
PLoS pathogens , 2011 | Pubmed ID: 21304889
The therapeutic potential of the humoral pattern recognition molecule PTX3 in chronic lung infection caused by Pseudomonas aeruginosa.
Journal of immunology (Baltimore, Md. : 1950) May, 2011 | Pubmed ID: 21441447
Dampening Host Sensing and Avoiding Recognition in Pseudomonas aeruginosa Pneumonia.
Journal of biomedicine & biotechnology , 2011 | Pubmed ID: 21785567
Role of Toll interleukin-1 receptor (IL-1R) 8, a negative regulator of IL-1R/Toll-like receptor signaling, in resistance to acute Pseudomonas aeruginosa lung infection.
Infection and immunity Jan, 2012 | Pubmed ID: 22025515
Oxidative stress and antioxidant therapy in cystic fibrosis.
Biochimica et biophysica acta May, 2012 | Pubmed ID: 22226887
Antibiotic pressure compensates the biological cost associated with Pseudomonas aeruginosa hypermutable phenotypes in vitro and in a murine model of chronic airways infection.
The Journal of antimicrobial chemotherapy Apr, 2012 | Pubmed ID: 22294647
MudPIT analysis of released proteins in Pseudomonas aeruginosa laboratory and clinical strains in relation to pro-inflammatory effects.
Integrative biology : quantitative biosciences from nano to macro Mar, 2012 | Pubmed ID: 22298109
Cystic fibrosis-niche adaptation of Pseudomonas aeruginosa reduces virulence in multiple infection hosts.
PloS one , 2012 | Pubmed ID: 22558188
Factors contributing to epidemic MRSA clones replacement in a hospital setting.
PloS one , 2012 | Pubmed ID: 22905220
Response of CFTR-deficient mice to long-term chronic Pseudomonas aeruginosa infection and PTX3 therapy.
The Journal of infectious diseases Jul, 2013 | Pubmed ID: 23087427
Analysis of Pseudomonas aeruginosa cell envelope proteome by capture of surface-exposed proteins on activated magnetic nanoparticles.
PloS one , 2012 | Pubmed ID: 23226459
Modelling co-infection of the cystic fibrosis lung by Pseudomonas aeruginosa and Burkholderia cenocepacia reveals influences on biofilm formation and host response.
PloS one , 2012 | Pubmed ID: 23284990
Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity.
Proceedings of the National Academy of Sciences of the United States of America Apr, 2013 | Pubmed ID: 23569238
Complete Genome Sequence of Persistent Cystic Fibrosis Isolate Pseudomonas aeruginosa Strain RP73.
Genome announcements , 2013 | Pubmed ID: 23908295
Anti-inflammatory action of lipid nanocarrier-delivered myriocin: therapeutic potential in cystic fibrosis.
Biochimica et biophysica acta Jan, 2014 | Pubmed ID: 24141140
Extended Staphylococcus aureus persistence in cystic fibrosis is associated with bacterial adaptation.
International journal of medical microbiology : IJMM Dec, 2013 | Pubmed ID: 24183484
BIIL 284 reduces neutrophil numbers but increases P. aeruginosa bacteremia and inflammation in mouse lungs.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society Mar, 2014 | Pubmed ID: 24183915
Pseudomonas aeruginosa reduces the expression of CFTR via post-translational modification of NHERF1.
Pflugers Archiv : European journal of physiology Mar, 2014 | Pubmed ID: 24595473
Adaptation of Pseudomonas aeruginosa in Cystic Fibrosis Airways Influences Virulence of Staphylococcus aureus In Vitro and Murine Models of Co-Infection.
PloS one , 2014 | Pubmed ID: 24603807
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados